GVIRF 2021 Day 1

GVIRF 2021: Keynote by Anthony Fauci, NIAID

GVIRF 2021: Epidemic and Pandemic Preparedness and Response

GVIRF 2021: Emerging Platforms

GVIRF 2021: Innovations in Vaccine Manufacturing

GVIRF 2021: Innovation in Vaccination

GVIRF 2021: Fenton Hall Introduction

GVIRF 2021 Day 2

GVIRF 2021: Keynotes by Bill Gates, Bill & Melinda Gates Foundation, and Anuradha Gupta, Gavi, the Vaccine Alliance

GVIRF 2021: HIV, TB & Malaria Vaccine R&D Update

GVIRF 2021: New and Improved Vaccines on the Horizon

GVIRF 2021: Controlled Human Infection Models for Vaccine R&D

GVIRF 2021: Vaccine development to access: is there a role for early policy consideration?

GVIRF 2021 Day 3

GVIRF 2021: Keynote by Soumya Swaminathan, WHO

GVIRF 2021: Shaping the Future: Equitable Access for All

GVIRF 2021: Prioritization for Vaccine R&D

GVIRF 2021: Immune Responses over the Life Course

GVIRF 2021: Building and Sustaining Uptake